Literature DB >> 18509110

Temperature-dependent cooperativity in donor-acceptor substrate binding to the human blood group glycosyltransferases.

Glen K Shoemaker1, Naoto Soya, Monica M Palcic, John S Klassen.   

Abstract

Affinities of the human blood group glycosyltransferases, alpha-(1-->3)-N-acetylgalactosaminyltransferase (GTA) and alpha-(1-->3)-galactosyltransferase (GTB) for their common acceptor substrate alpha-l-Fucp-(1-->2)-beta-d-Galp-O(CH2)(7)CH3 (1), in the absence and presence of bound uridine 5'-diphosphate (UDP) and Mn2+ were determined using temperature-controlled electrospray ionization mass spectrometry. The presence of bound UDP and Mn(2+) in the donor binding site has a marked influence on the thermodynamic parameters for the association of 1 with GTA and GTB. Both the enthalpy and entropy of association (DeltaH(a), DeltaS(a)) decrease significantly. However, the free energy of association (DeltaG(a)) is unchanged at physiological temperature. The differences in the DeltaH(a) and DeltaS(a) values determined in the presence and absence of bound UDP are attributed to structural changes in the glycosyltransferases induced by the simultaneous binding of 1 and UDP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509110     DOI: 10.1093/glycob/cwn043

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  18 in total

1.  Affinities of human histo-blood group antigens for norovirus capsid protein complexes.

Authors:  Ling Han; Elena N Kitova; Ming Tan; Xi Jiang; Benjamin Pluvinage; Alisdair B Boraston; John S Klassen
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

2.  Reliable determinations of protein-ligand interactions by direct ESI-MS measurements. Are we there yet?

Authors:  Elena N Kitova; Amr El-Hawiet; Paul D Schnier; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2012-01-21       Impact factor: 3.109

3.  Quantifying labile protein-ligand interactions using electrospray ionization mass spectrometry.

Authors:  Amr El-Hawiet; Elena N Kitova; Lan Liu; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2010-07-29       Impact factor: 3.109

4.  Identifying nonspecific ligand binding in electrospray ionization mass spectrometry using the reporter molecule method.

Authors:  Nian Sun; Jiangxiao Sun; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-25       Impact factor: 3.109

5.  Nonspecific interactions between proteins and charged biomolecules in electrospray ionization mass spectrometry.

Authors:  Nian Sun; Naoto Soya; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2009-12-21       Impact factor: 3.109

6.  Measuring positive cooperativity using the direct ESI-MS assay. Cholera toxin B subunit homopentamer binding to GM1 pentasaccharide.

Authors:  Hong Lin; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2014-01       Impact factor: 3.109

7.  Quantifying protein-fatty acid interactions using electrospray ionization mass spectrometry.

Authors:  Lan Liu; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-01       Impact factor: 3.109

8.  NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments.

Authors:  Christoph Rademacher; Jens Landström; Nora Sindhuwinata; Monica M Palcic; Göran Widmalm; Thomas Peters
Journal:  Glycoconj J       Date:  2010-03-09       Impact factor: 2.916

Review 9.  Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Jake Pawlowski; Guanbo Wang
Journal:  J Pharm Biomed Anal       Date:  2020-02-12       Impact factor: 3.935

10.  Electrothermal supercharging of proteins in native MS: effects of protein isoelectric point, buffer, and nanoESI-emitter tip size.

Authors:  Daniel N Mortensen; Evan R Williams
Journal:  Analyst       Date:  2016-07-21       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.